Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guidelines – Management of Breathlessness in Patients with Cancer

Management of Breathlessness in Patients with Cancer: ESMO Clinical Practice Guidelines

Published in 2020 – ESMO Open (2020)
Authors: D. Hui, M. Maddocks, M.J. Johnson, M. Ekström, S.T. Simon, A.C. Ogliari, S. Booth & C.I. Ripamonti on behalf of the ESMO Guidelines Committee

This ESMO Clinical Practice Guideline provides key recommendations on the management of breathlessness in cancer patients. Authorship includes a multidisciplinary group of experts from different institutions and countries in Europe and worldwide. Key treatment recommendations are provided, including levels of evidence and grades of recommendation where applicable. Routine assessment of breathlessness and its impact facilitates timely interventions. Key non-pharmacological measures include fan, breathing retraining, mobility aids, education and pulmonary rehabilitation. The main pharmacological option is opioids. Supplemental oxygen, non-invasive ventilation and high-flow oxygen therapy may be considered.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings